• GKT137831 for Reliable Cell Assays

  2026-09-18

  A scenario-driven guide to using GKT137831 (SKU B4763) in cell viability, proliferation, cytotoxicity, and oxidative-stress workflows. It connects dose selection, solvent control, ROS interpretation, ferroptosis context, and supplier evaluation to practical laboratory decisions.

• TMEM16F, Ferroptosis, and Tumor Immune Rejection

  2026-09-18

  Yang et al. identify TMEM16F-mediated phospholipid scrambling as a late membrane-protective mechanism that limits ferroptotic plasma membrane failure. Disrupting this pathway increases lytic death, danger-signal release, tumor control, and responsiveness to PD-1 blockade, providing a mechanistic link between ferroptosis execution and antitumor immunity.

• Vitamin C in ROS-Driven Senescence Assays

  2026-09-17

  Build a redox-aware HEI-OC1 senescence workflow with ascorbic acid, matched controls, and orthogonal readouts instead of relying on viability alone. The same product also supports carefully separated cancer research applications, where dose and cellular context determine whether Vitamin C behaves as a protective perturbation or an anticancer agent.

• VEGFC–VEGFR-3 Signaling in NASH Fibrosis

  2026-09-17

  This Phytomedicine study identifies a hepatocyte-derived VEGFC–VEGFR-3 and CCL2/CCR2 regulatory axis that promotes inflammatory macrophage recruitment and sustains high-fat diet-induced hepatic fibrosis. By combining pharmacological inhibition, hepatocyte-specific Vegfc deletion, patient data, and hepatocyte–macrophage co-culture models, the work positions VEGFR-3 signaling as a mechanistic target for investigating NASH-associated fibrosis.

• Fasudil (HA-1077) HCl: ROCK Workflow Guide

  2026-09-16

  Fasudil (HA-1077) HCl provides a practical chemical-probe strategy for Rho/ROCK pathway inhibition, with applications spanning cell migration, proliferation, and apoptosis assays. This workflow also shows how to connect ROCK perturbation with Hippo-pathway readouts without overstating evidence from cataract models.

• Glucocorticoids, Kv2.1, and CaV1.2 Calcium Signals

  2026-09-16

  This 2024 Journal of Neuroscience study identifies a rapid, non-genomic mechanism by which glucocorticoids suppress CaV1.2-mediated calcium signals in hippocampal neurons. The work links reduced cAMP–PKA activity to endocytosis of Kv2.1 channel clusters, revealing how membrane organization—not only channel gating—controls acute glucocorticoid effects in the brain.

• IAM LC vs LEKC for Pulmonary Permeability

  2026-09-15

  This reference study provides a direct biomimetic comparison of immobilised artificial membrane liquid chromatography and liposome electrokinetic capillary chromatography for drug–membrane partitioning and pulmonary permeability assessment. LEKC more closely reflected apparent lung permeability by capturing hydrophobic and electrostatic interactions, whereas IAM LC offered broader compound coverage and simpler, more automation-ready analysis.

• Reframing CYP2C19 Studies with (S)-Mephenytoin

  2026-09-15

  How (S)-Mephenytoin can connect CYP2C19 enzymology with hiPSC-derived intestinal organoids to improve mechanistic pharmacokinetic studies and translational decision-making.

• RCN2, PPP2CA, and Cisplatin Resistance in ESCC

  2026-09-14

  This study identifies RCN2 as a driver of esophageal squamous cell carcinoma metastasis and cisplatin resistance through UBR5-dependent degradation of PPP2CA. Its integrated molecular, biochemical, cellular, and animal-model evidence places the RCN2–PPP2CA–PI3K-AKT axis at the center of a potentially actionable resistance mechanism.

• Annexin V-PE Reagent for CAR-T Assays

  2026-09-14

  The Annexin V-PE Reagent converts early phosphatidylserine exposure into a rapid, measurable endpoint for CAR-T cytotoxicity, CD38 binder comparison, and fratricide studies. Its flow cytometry and microscopy compatibility helps connect structural affinity engineering with practical cell-death biology.

• Golgi-Tracker Green: From Golgi Shape to Cell State

  2026-09-13

  Golgi-Tracker Green enables selective live-cell Golgi imaging while preserving the opportunity to study membrane trafficking and organelle stress. This article connects BODIPY FL-labeled C5-ceramide labeling with assay decisions inspired by recent cancer biology research.

• TLS, CD40 and STING in ESCC B-Cell Activation

  2026-09-12

  This 2025 study links tertiary lymphoid structures in treatment-naïve esophageal squamous cell carcinoma with favorable survival and identifies an IRF4-centered mechanism of B-cell activation. Its mechanistic model proposes that CD40 and STING compete for TRAF2, coupling ubiquitination and phosphorylation changes to non-canonical NF-κB signaling and TLS-associated immunity.

• HyperScribe All in One mRNA Synthesis Kit Plus 1

  2026-09-11

  Generate ARCA-capped, 5mCTP/ψUTP-modified, polyadenylated mRNA in an integrated T7 transcription workflow. The kit is especially useful when translation performance, reduced innate immune sensing, and consistent RNA preparation matter for vaccine, expression, and RNAi studies.

• Promethazine HCl for Reliable Cell Assays

  2026-09-11

  Promethazine HCl (SKU B4784) offers a defined phenothiazine reagent format for cell viability, macrophage, autophagy, ROS, and histaminergic signaling studies. This scenario-based guide explains how to control vehicle effects, distinguish cytotoxicity from pathway activation, and select a practical solid or 10 mM DMSO format.

• EPO-MSC Mitochondrial Transfer in Asthma

  2026-09-10

  The reference study shows that erythropoietin-modified bone marrow mesenchymal stem cells improve experimental asthma by enhancing HO-1-associated mitochondrial activation and transfer to injured airway epithelial cells. Its combination of in vivo transplantation, an epithelial stress model, mitochondrial tracking, and tunnelling nanotube analysis provides a mechanistic framework for studying cell-to-cell organelle rescue in airway inflammation.

3619 records 1/242 page Next 12345 下5页 Last page